Immix Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMMX and other ETFs, options, and stocks.About IMMX
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
CEOIlya Rachman
CEOIlya Rachman
Employees21
Employees21
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2012
Founded2012
Employees21
Employees21
IMMX Key Statistics
Market cap186.19M
Market cap186.19M
Price-Earnings ratio-7.07
Price-Earnings ratio-7.07
Dividend yield—
Dividend yield—
Average volume514.98K
Average volume514.98K
High today$5.67
High today$5.67
Low today$4.75
Low today$4.75
Open price$4.93
Open price$4.93
Volume1.11M
Volume1.11M
52 Week high$5.67
52 Week high$5.67
52 Week low$1.34
52 Week low$1.34
Stock Snapshot
With a market cap of 186.19M, Immix Biopharma(IMMX) trades at $5.60. The stock has a price-to-earnings ratio of -7.07.
On 2025-12-07, Immix Biopharma(IMMX) stock moved within a range of $4.75 to $5.67. With shares now at $5.60, the stock is trading +17.9% above its intraday low and -1.2% below the session's peak.
Trading volume for Immix Biopharma(IMMX) stock has reached 1.11M, versus its average volume of 514.98K.
The stock's 52-week range extends from a low of $1.34 to a high of $5.67.
The stock's 52-week range extends from a low of $1.34 to a high of $5.67.
People also own
Based on the portfolios of people who own IMMX. This list is generated using Robinhood data, and it’s not a recommendation.